Study of psycho-social impairment in patients presenting with age related macular degeneration in a tertiary eye care hospital

Parul Danayak, Chinmay Jani, Anita Verma, Parth Shah

Abstract


Background: Age Related Macular Degeneration (ARMD) is an eye condition affecting old age people causing severe vision loss. This study was carried out to assess the psycho-social impairment in the ARMD patients and compare it with the normal eye patients.

Methods: A Two study groups were made: 1. ARMD patients. 2. Control group patients. Patients of both the groups were made to fill “The validated Gujarati version of: General Health Quality Questionnaire-28 (GHQ 28)”. Self-scoring was done according to 0-1-2-3 lower to higher disability respectively.

Results: Prevalence GHQ Mean score of ARMD patients was 34.27 and that of normal eye patients was 24.66. 80.85% of ARMD patients and 26.73% of normal eye patients were psychosocially impaired.

Conclusion: ARMD patients are psychosocially more impaired as compared to control group patients (p value <0.001, highly significant).

 


Keywords


ARMD (Age Related Macular Degeneration), Psycho-social impairment, GHQ-28 (General Health Questionnaire)

Full Text:

PDF

References


Berman K, Brodaty H. Psychosocial effects of age-related macular degeneration. Int Psychogeriatr. 2006;18(3):415-28.

Woo JH, Sanjay S, Au Eong KG. The epidemiology of age-related macular degeneration in the Indian subcontinent. Acta Ophthalmol. 2009;87(3):262-9.

Goldberg DP, Hillier VF. A scaled version of the general health questionnaire. Psychologic Med. 1979;9(1):139-45.

Makowska Z, Merecz D, Moscicka A, Kolasa W. The validity of general health questionnaires, GHQ-12 and GHQ-28, in mental health studies of working people. Int J Occupat Med Environment Health. 2002;15(4):353-62.

Richard C, Lussier MT, Gagnon R, Lamarche L. GHQ-28 and cGHQ-28: implications of two scoring methods for the GHQ in a primary care setting. Soc Psychiatr Psychiatric Epidemiol. 2004;39(3):235-43.

Koeter MW. Validity of the GHQ and SCL anxiety and depression scales: a comparative study. J Affect Dis. 1992;24(4):271-9.

Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychologic Med. 1997;27(1):191-7.

Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116(4):514-20.

Hassell JB, Lamoureux EL, Keeffe JE. Impact of age related macular degeneration on quality of life. Br J Ophthalmol. 2006;90(5):593-6.

Jivraj J, Jivraj I, Tennant M, Rudnisky C. Prevalence and impact of depressive symptoms in patients with age-related macular degeneration. Canadian J Ophthalmol. 2013;48(4):269-73.

Banerjee A, Kumar S, Kulhara P, Gupta A. Prevalence of depression and its effect on disability in patients with age-related macular degeneration. Indian J Ophthalmol. 2008;56(6):469-74.

Yuzawa M, Fujita K, Tanaka E, Wang EC. Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice. Clin Ophthalmol. 2013;7:1325-32.

Yuzawa M, Suzukamo Y, Zeon L, Fukuhara S. Quality of life evaluation of age-related macular degeneration. Nippon Ganka Gakkai zasshi. 2004;108(6):368-74.

Ambrecht AM, Findlay C, Aspinall P, Dhillon B. Do patients with age related maculopathy and cataract benefit from cataract surgery? Br J Ophthalmol. 1999;83(2):253-4.

Moon SW, Oh J, Yu HG, Cho HY, Song SJ. Incidence and risk factors for macular hemorrhage following intravitreal ranibizumab injection for neovascular age-related macular degeneration. J Ocular Pharmacol Therapeut. 2013;29(6):556-9.

Krishnaiah S, Das T, Nirmalan PK, Nutheti R, Shamanna BR, Rao GN et al. Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India. Invest Ophthalmol Visual Sci. 2005;46(12):4442-9.

Klein R, Klein BE, Jensen SC, Moss SE. The relation of socioeconomic factors to the incidence of early age-related maculopathy: the Beaver Dam eye study. Am J Ophthalmol. 2001;132(1):128-31.